MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,515 Cr | ₹190,193 Cr | ₹1,991 Cr | ₹165 Cr | ₹14,447 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,515 Cr |
| Mar2024 | ₹190,193 Cr |
| Mar2023 | ₹1,991 Cr |
| Mar2022 | ₹165 Cr |
| Mar2021 | ₹14,447 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,515 Cr | -98.68 | |
| Mar2024 | ₹190,193 Cr | 9,454.83 | |
| Mar2023 | ₹1,991 Cr | 1,107.04 | |
| Mar2022 | ₹165 Cr | -98.86 | |
| Mar2021 | ₹14,447 Cr | - | |
Compare Operating Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,484.7 Cr | -1.9% | -7% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.9% |
-7% |
-13% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses